Panobinostat (Standard)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Panobinostat (Standard)
Description:
Panobinostat (Standard) (LBH589 (Standard) ) is the analytical standard of Panobinostat (HY-10224) . This product is intended for research and analytical applications. Panobinostat is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities[1][2]. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells[4]. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma[3].Product Name Alternative:
LBH589 (Standard) ; NVP-LBH589 (Standard)UNSPSC:
12352005Hazard Statement:
H301+H331, H315, H318, H360, H373Target:
Apoptosis; Autophagy; HDAC; HIV; Reference StandardsRelated Pathways:
Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; OthersApplications:
COVID-19-anti-virusField of Research:
Cancer; InfectionPurity:
98.09Smiles:
ONC(/C=C/C(C=C1)=CC=C1CNCCC2=C(C)NC3=CC=CC=C23)=OMolecular Formula:
C21H23N3O2Molecular Weight:
349.43Precautions:
H301+H331, H315, H318, H360, H373References & Citations:
[1]Scuto A, et al. The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells. Blood. 2008 May 15;111 (10) :5093-100.|[2]Crisanti MC, et al. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Mol Cancer Ther. 2009 Aug;8 (8) :2221-31. |[3]Ocio EM, et al. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. Haematologica. 2010 May;95 (5) :794-803.|[4]Barton K, et al. Broad activation of latent HIV-1 in vivo. Nat Commun. 2016;7:12731. Published 2016 Sep 8.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C, sealed storage, away from light and moistureScientific Category:
Reference StandardsClinical Information:
No Development ReportedCAS Number:
[404950-80-7]
